More Bayer Drug Claims Are Settled
Jun 16, 2004 | AP German drug maker Bayer AG has reached settlements in 2,710 cases related to a cholesterol-lowering drug it produced that has been linked to a rare muscle-wasting syndrome, the company said Wednesday.Bayer pulled Lipobay, marketed as Baycol in the United States, in August 2001 after it was linked to the syndrome and about 100 patient deaths.
In a regular update on its Web site, the company said 8,563 lawsuits are still pending, compared to the 8,895 it reported in May.










